Showing results (251-260 of 271) with videos related to

Sort By:
Pageof 28
The Journal of Bone and Joint Surgery. American Volume|August 19, 2022
A Framework and Blueprint for Building Capacity in Global Orthopaedic Surgical OutreachLauren M Shapiro, Jessica M Welch, Maya Chatterjee, et al.
Cell Reports. Medicine|May 21, 2025
Chikungunya virus-specific CD4+ T cells are associated with chronic chikungunya viral arthritic disease in humansRimjhim Agarwal, James Chang, Fernanda H Côrtes, et al.
Journal of Gynecologic Oncology|December 22, 2024
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)Jung-Yun Lee, David Tan, Isabelle Ray-Coquard, et al.
Neurointervention|February 8, 2022
The Woven EndoBridge Device for the Treatment of Intracranial Aneurysms: Initial Clinical Experience within an Australian PopulationJay Gajera, Julian Maingard, Michelle Foo, et al.
Cell|June 28, 2022
Humoral and cellular immune memory to four COVID-19 vaccinesZeli Zhang, Jose Mateus, Camila H Coelho, et al.
JACC. Cardiovascular Imaging|October 29, 2015
Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation From the CoreValve U.S. Pivotal TrialJae K Oh, Stephen H Little, Sahar S Abdelmoneim, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2022
Humoral and cellular immune memory to four COVID-19 vaccinesZeli Zhang, Jose Mateus, Camila H Coelho, et al.
Investigational New Drugs|December 22, 2015
A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)Joanne W Chiu, Sebastien J Hotte, Christian K Kollmannsberger, et al.
Cell Host & Microbe|February 16, 2022
Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination statusEsther Dawen Yu, Eric Wang, Emily Garrigan, et al.
The Journal of Infectious Diseases|April 16, 2023
A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of ConcernNicholas P Wayham, Ariel R Niedecken, Jan Fredrik Simons, et al.
Pageof 28